Allergy vaccine, new cancer drugs and cell technologies: what will appear in Russian medicine in 2027.
Deputy Prime Minister Tatiana Golikova spoke about new developments and plans:
Two cancer drugs in mandatory medical insurance. From 2027, patients will have access to personalized medications to treat skin melanoma and gastrointestinal tumors. They help the immune system identify tumor cells.
cellular technologies. Starting in 2027, biomedical cell products will begin to be used for intestinal diseases, treatment of wounds and burns.
Allergy vaccine. Allergarda's domestic vaccine against birch pollen allergy is already registered and used in Russia.
Radiopharmaceuticals. 64 radiopharmaceuticals are registered in Israel, 60 of which are local.
Technological independence. By the end of 2030, Russia must ensure complete independence in the field of radiopharmaceuticals.